BlackRock’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,575,092
Closed -$142M 5402
2024
Q1
$142M Buy
3,575,092
+516,594
+17% +$15.2M ﹤0.01% 1862
2023
Q4
$58.3M Buy
3,058,498
+706,581
+30% +$9.82M ﹤0.01% 2382
2023
Q3
$26.9M Buy
2,351,917
+70,225
+3% +$864K ﹤0.01% 2769
2023
Q2
$23.5M Buy
2,281,692
+728,772
+47% +$6.57M ﹤0.01% 2929
2023
Q1
$12M Buy
1,552,920
+116,060
+8% +$925K ﹤0.01% 3222
2022
Q4
$10.6M Buy
1,436,860
+509,137
+55% +$3.25M ﹤0.01% 3373
2022
Q3
$6.68M Buy
927,723
+49,355
+6% +$407K ﹤0.01% 3627
2022
Q2
$7.48M Buy
878,368
+155,230
+21% +$1.34M ﹤0.01% 3643
2022
Q1
$6.49M Sell
723,138
-5,710
-0.8% -$49.4K ﹤0.01% 3810
2021
Q4
$10.1M Buy
728,848
+181,066
+33% +$2.24M ﹤0.01% 3668
2021
Q3
$5.84M Buy
547,782
+3,627
+0.7% +$33.4K ﹤0.01% 3894
2021
Q2
$4.9M Buy
544,155
+517,399
+1,934% +$5.62M ﹤0.01% 3887
2021
Q1
$284K Buy
26,756
+1,001
+4% +$12.5K ﹤0.01% 4685
2020
Q4
$325K Sell
25,755
-4,990
-16% -$49K ﹤0.01% 4406
2020
Q3
$270K Buy
30,745
+841
+3% +$7.69K ﹤0.01% 4355
2020
Q2
$291K Buy
29,904
+6,363
+27% +$27.5K ﹤0.01% 4305
2020
Q1
$68K Sell
23,541
-540
-2% -$1.68K ﹤0.01% 4415
2019
Q4
$92K Sell
24,081
-120
-0.5% -$374 ﹤0.01% 4458
2019
Q3
$96K Sell
24,201
-660
-3% -$2.83K ﹤0.01% 4450
2019
Q2
$105K Sell
24,861
-85
-0.3% -$491 ﹤0.01% 4466
2019
Q1
$171K Sell
24,946
-854
-3% -$5.32K ﹤0.01% 4265
2018
Q4
$94K Sell
25,800
-244
-0.9% -$1.2K ﹤0.01% 4363
2018
Q3
$165K Buy
26,044
+549
+2% +$3.84K ﹤0.01% 4364
2018
Q2
$192K Buy
25,495
+3,532
+16% +$29.1K ﹤0.01% 4311
2018
Q1
$177K Sell
21,963
-153
-0.7% -$1.51K ﹤0.01% 4235
2017
Q4
$247K Buy
22,116
+755
+4% +$8.22K ﹤0.01% 4176
2017
Q3
$247K Buy
21,361
+1,932
+10% +$18.1K ﹤0.01% 4188
2017
Q2
$187K Sell
19,429
-3,363
-15% -$32.2K ﹤0.01% 4265
2017
Q1
$266K Buy
+22,792
New +$231K ﹤0.01% 4147